QR Kodea

Post-treatment changes in bowel and urinary function in prostate cancer patients treated with moderate or ultra-hypofractionation: A prospective cohort study

Objective/Purpose: Hypofractionation (HF) has been established as safe in prostate cancer (PCa) trial populations. We evaluated post-treatment changes in health-related quality of life (HRQoL) outcomes after moderate (MHF) or ultra-hypofractionated (UHF) radiotherapy in a real-world PCa patient popu...

Deskribapen osoa

Gorde:
Egile Nagusiak: W.D. Heemsbergen, F. Sinzabakira, K.C. de Vries, M. Franckena, M.E.M.C. Christianen, F.E. Froklage, H. Westerveld, L. Incrocci
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2025-07-01
Saila:Clinical and Translational Radiation Oncology
Gaiak:
Prostate cancer
Hypofractionation
Radiotherapy
EPIC
EQ5D5L
Health-related quality of life
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S240563082500045X
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak